InjuryBoard Philadelphia Archives

• Nephrogenic Systemic Fibrosis and Gadolinium Contrast Agents

  Jamie Sheller | March 31, 2007 2:56 PM | 0 Comments
  Category: Defective & Dangerous Products

  Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD) is a potentially fatal skin disorder found in people with renal failure. Typically, a patient with NSF/NFD has moderate to end-stage kidney disease. The disorder has been linked to gadolinium-based contrast agents used in imaging studies, such as MRI, of patients with moderate to end-stage kidney disease. It is...

• Warnings About Arsenic In Mineral Water

  Jamie Sheller | March 28, 2007 2:07 PM | 0 Comments
  Category: Defective & Dangerous Products

  According to the FDA, consumers should avoid drinking Jermuk brand of mineral water. The latest warning comes several weeks after the FDA's initial warning about the risk of arsenic in the mineral water. Arsenic is a poison and is known to cause cancer in humans. Since the FDA's earlier warning, Andreas Andreasyan DBA Arnaz & Nelli Co., the distributor of Jermuk, has recalled several brands...

• What Is Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis?

  Jamie Sheller | March 24, 2007 8:30 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Nephrogenic Fibrosing Dermopathy (NFD) is an acquired disorder found in patients with renal failure. The disorder is also known as Nephrogenic Systemic Fibrosis (NSF). This disorder causes fibrotic nodules and plaques to develop on the skin. Nephrogenic Fibrosing Dermopathy or Nephrogenic Systemic Fibrosis can also lead to limited range of motion, due to tightening of the skin and impaired...

• Anemia Drugs Need New Warnings

  Jamie Sheller | March 22, 2007 7:04 AM | 0 Comments
  Category: FDA & Prescription Drugs

  Cancer and kidney disease patients have an increased risk of serious problems, including death, with the use of anemia drugs. The FDA has issued new warnings about the anemia drugs, including Procrit, Epogen and Aranesp, ordering more careful prescribing. According to the FDA, studies show that overuse of the anemia drugs can lead to blood clots, strokes and heart attacks in patients with...

• Treatment for Nephrogenic Systemic Fibrosis

  Jamie Sheller | March 17, 2007 3:28 PM | 0 Comments
  Category: Defective & Dangerous Products

  Nephrogenic Sytemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD), is a disorder typically suffered by patients with kidney failure. It may cause severe skin lesions, masses on the skin and can affect the joints. There is currently no cure for Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy. However, early diagnosis and treatment may slow the progress of the...

• New Warnings Ordered For Sleep Aids

  Jamie Sheller | March 15, 2007 7:45 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Due to some rare but serious side effects, the FDA is ordering new warnings for the labels of prescription sleep aids. The makers of all sedative-hypnotic drugs have been ordered to strengthen their warning labels regarding the risk of "complex sleep-related behaviors" and severe allergic reactions. Some of the potential adverse effects include driving and eating while asleep, with no memory...

• Nephrogenic Systemic Fibrosis

  Jamie Sheller | March 09, 2007 12:07 PM | 0 Comments
  Category: Defective & Dangerous Products

  Though nephrogenic systemic fibrosis is primarily a skin disorder, it may affect other organs. The disease affects people with renal insufficiency. NSF can be diagnosis with clinical findings and tissue diagnosis. Originally the disease was termed nephrogenic fibrosing dermopathy because it was thought to be largely focused on the skin. However, the name was later changed to nephrogenic...

• More Problems With Bausch & Lomb

  Jamie Sheller | March 07, 2007 1:10 PM | 0 Comments
  Category: Defective & Dangerous Products

  Bausch & Lomb has recalled certain lots of its ReNu MultiPlus contact lens solution. The company said it decided to issue the recall because the solution may have elevated levels of iron, which may cause discoloration of the product and shorten its shelf life. The ReNu MultiPlus solution was manufactured in the company's Greenville, South Carolina plant. The recalled lots have been...

• About Nephrogenic Fibrosing Dermopathy

  Jamie Sheller | March 01, 2007 11:34 AM | 0 Comments
  Category: FDA & Prescription Drugs

  Nephrogenic Fibrosing Dermopathy (NFD), also known as Nephrogenic Systemic Fibrosis (NSF), is a skin disease that was first identified in 1997. NFD/NSF has been identifed in people with impaired renal function or kidney disease. Some characteristics of nephrogenic fibrosing dermopathy or nephrogenic system fibrosis include tight, rigid skin that may make it difficult to bend the joints. The...